MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

11 Nov 2022 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2022, as compared to corresponding quarter of last year.The Net Profit of the company vaulted to 19310.00% to Rs. 19.41  millions from Rs. 0.10 millions in the previous quarter.OP of the company witnessed a marginal growth to 19.41 millions from 0.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 0.00 12.23 0.00 -15.37 24.75 -162.10 21.62 0.15 14313.33
Other Income 20.50 -1.64 -1350.00 20.50 -1.64 -1350.00 0.07 0.00 0.00
PBIDT 19.41 0.10 19310.00 3.51 2.12 65.57 -0.08 -16.03 -99.50
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 19.41 0.10 19310.00 3.51 2.12 65.57 -0.08 -16.03 -99.50
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 19.41 0.10 19310.00 3.51 2.12 65.57 -0.08 -16.03 -99.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 19.41 0.10 19310.00 3.51 2.12 65.57 -0.08 -16.03 -99.50
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 0.00 0.82 0.00 -22.84 8.57 -366.61 -0.37 -10686.67 -100.00
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..